Tarlatamab for treating small-cell lung cancer that has progressed after platinum-based chemotherapy ID6617

  • In development
  • GID-TA11812
  • Expected publication date: TBC

Documents

Documents created during the development process.

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: ID6617